Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Acquisitions & Divestments: 2015-2017

Historic Change in Acquisitions & Divestments for Adma Biologics (ADMA) over the last 3 years, with Dec 2017 value amounting to $5.4 million.

  • Adma Biologics' Change in Acquisitions & Divestments rose 106.67% to $245,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $18.4 million, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2017, which is 67.64% down from last year.
  • Adma Biologics' Change in Acquisitions & Divestments amounted to $5.4 million in FY2017, which was down 67.64% from $16.7 million recorded in FY2016.
  • Adma Biologics' Change in Acquisitions & Divestments' 5-year high stood at $16.7 million during FY2016, with a 5-year trough of $5.4 million in FY2017.
  • In the last 3 years, Adma Biologics' Change in Acquisitions & Divestments had a median value of $16.4 million in 2015 and averaged $12.8 million.
  • Per our database at Business Quant, Adma Biologics' Change in Acquisitions & Divestments rose by 1.48% in 2016 and then crashed by 67.64% in 2017.
  • Adma Biologics' Change in Acquisitions & Divestments (Yearly) stood at $16.4 million in 2015, then grew by 1.48% to $16.7 million in 2016, then plummeted by 67.64% to $5.4 million in 2017.